Oncobiologics (OTLK)
(Real Time Quote from BATS)
$1.99 USD
-0.02 (-1.00%)
Updated Aug 5, 2025 03:46 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2025
Time: -- |
6/2025 | $-0.42 | 0.00% |
Earnings Summary
For their last quarter, Oncobiologics (OTLK) reported earnings of -$0.40 per share, beating the Zacks Consensus Estimate of $-0.55 per share. This reflects a positive earnings surprise of 27.27%. Look out for OTLK's next earnings release expected on August 13, 2025. For the next earning release, we expect the company to report earnings of -$0.42 per share, reflecting a year-over-year increase of 49.4%.
Earnings History
Price & Consensus
Zacks News for OTLK
OTLK Stock Falls on Failure to Meet Non-Inferiority Goal in AMD Study
OTLK: What are Zacks experts saying now?
Zacks Private Portfolio Services
OTLK FAQs
Based on past history, Zacks believes Oncobiologics, Inc. (OTLK) will report their next quarter earnings on August 13, 2025. For the next earning release, we expect the company to report earnings of -0.42 per share, reflecting a year-over-year increase of 49.40.
Based on past history, Zacks believes Oncobiologics, Inc. (OTLK) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on August 13, 2025.
The Zacks Consensus Estimate for Oncobiologics, Inc. (OTLK) for the quarter ending June 2025 is $-0.42 a share. We expect Oncobiologics, Inc. (OTLK) to report earnings in line with the consensus estimate of $-0.42 per share
In the earnings report for the quarter ending in June 2024, Oncobiologics, Inc. (OTLK) announced earnings of $-0.83 per share versus the Zacks Consensus Estimate of $-1.06 per share, representing a surprise of -21.70%.